-
February 27, 2006 Lupin-Aspen sign Joint Venture
-
February 27, 2006 Lupin LCTL Divestment
-
February 21, 2006 Lupin to Reorganise Sale Structure for Suprax
-
February 20, 2006 Lupin sells Intellectual Property on Perindopril to Servier
-
February 7, 2006 Lupin receives US FDA approval for Sertraline
-
January 19, 2006 Lupin and Aspen decide not to pursue their MOU
-
January 17, 2006 Lupin FY 2006-07 Q3 Net Profit up by 27 % at Rs. 560 mn
-
January 2, 2006 Lupin gets tentative US FDA approval for Sertraline
-
December 20, 2005 Lupin launches novel cholesterol-fighter EZEDOC
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications